Profile image
Story Views

Last Hour:
Last 24 Hours:

Epiomic Epidemiology Series: Chronic Hepatitis C Market Research Report – Industry Analysis, Trends, Share, Demand and Forecast Till 2027

Wednesday, February 15, 2017 22:55
% of readers think this story is Fact. Add your two cents.

(Before It's News)

A new report published by Research Beam, titled, Epiomic Epidemiology Series: Chronic Hepatitis C Forecast in 12 Major Markets 2017-2027″, states that the global Chronic Hepatitis C market is expected to reach $XXX million by 2027, growing at a CAGR of XXX% from 2017 to 2027.

For further inquiries, about Global Extremity Reconstruction Market, Request Sample >>>>

Hepatitis C is a single-stranded RNA virus that infects and damages the liver. In most cases, hepatitis C causes no noticeable symptoms until the liver has been significantly damaged. Symptoms are often vague such as flu-like muscle aches and fatigue.

This report provides the current prevalent population for Chronic Hepatitis C across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Brazil, Japan, Russia, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Chronic Hepatitis C have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Browse the Full Global Extremity Reconstruction Market – Global Scenario, Industry Outlook, Share, Industry Analysis, Size, Trends and Forecast, 2014 – 2022 Report at -

Chronic hepatitis C is most often associated with co-infections with other chronic viral infections including:

  • HIV Co-infection
  • HBV Co-infection
  • HCV co-infection

Likely downstream events associated with chronic HCV infection include:

  • Cirrhosis of the liver
  • Hepatocellular carcinoma
  • Excess mortality associated with liver disease / decompensated liver function
  • This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

    Reason to buy

  • Able to quantify patient populations in global Chronic Hepatitis C market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Chronic Hepatitis C and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Chronic Hepatitis C prevalent population.
  • Identify sub-populations within Crohn’s disease which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Chronic Hepatitis C patients.

About Us:

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.